Skip Nav Destination
Issues
1 December 2019
-
Cover Image
Cover Image
The image shows a lung adenocarcinoma with solid growth pattern. By comprehensive nextgeneration sequencing (NGS), this tumor had an identical genomic profile to a previously resected adenocarcinoma with entirely different, better-differentiated histologic features. This illustrates histologic progression of lung adenocarcinoma during metastasis, and the utility of NGS in clinical practice for confirming clonally related tumors despite histologic differences. For details, see the article by Chang and colleagues on page 7113 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Reviews
Perspectives
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran; Andrew Hruszkewycz; Howard I. Scher; Jeffrey Hildesheim; Jennifer Isaacs; Evan Y. Yu; Kathleen Kelly; Daniel Lin; Adam Dicker; Julia Arnold; Toby Hecht; Max Wicha; Rosalie Sears; David Rowley; Richard White; James L. Gulley; John Lee; Maria Diaz Meco; Eric J. Small; Michael Shen; Karen Knudsen; David W. Goodrich; Tamara Lotan; Amina Zoubeidi; Charles L. Sawyers; Charles M. Rudin; Massimo Loda; Timothy Thompson; Mark A. Rubin; Abdul Tawab-Amiri; William Dahut; Peter S. Nelson
Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN)
Holly A. Massett; Grace Mishkin; Jeffrey A. Moscow; Amy Gravell; Michael Steketee; Martha Kruhm; Sae H. Han; Barbara Barry; Michael Montello; James Zwiebel; Jeffrey S. Abrams; James H. Doroshow; S. Percy Ivy
Clinical Trial Brief Report
Clinical Trials: Targeted Therapy
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes; Neeta Pandit-Taskar; Joseph A. O'Donoghue; Simone Krebs; Kevin D. Staton; Serge K. Lyashchenko; Jason S. Lewis; Nitya Raj; Mithat Gönen; Christian Lohrmann; Lisa Bodei; Wolfgang A. Weber
Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
Reena P. Thomas; Seema Nagpal; Michael Iv; Scott G. Soltys; Sophie Bertrand; Judith S. Pelpola; Robyn Ball; Jaden Yang; Vandana Sundaram; Sophia B. Chernikova; Jonathan Lavezo; Donald Born; Hannes Vogel; J. Martin Brown; Lawrence D. Recht
Author Choice
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study
Daniel Morgensztern; Benjamin Besse; Laurent Greillier; Rafael Santana-Davila; Neal Ready; Christine L. Hann; Bonnie S. Glisson; Anna F. Farago; Afshin Dowlati; Charles M. Rudin; Sylvestre Le Moulec; Satwant Lally; Sreeni Yalamanchili; Jürgen Wolf; Ramaswamy Govindan; David P. Carbone
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial
Li Li; Liyan Jiang; Yubo Wang; Yizhuo Zhao; Xiao-Ju Zhang; Guoming Wu; Xiangdong Zhou; Jianguo Sun; Jun Bai; Biyong Ren; Kun Tian; Zhi Xu; Hua-liang Xiao; Qi Zhou; Rui Han; Hengyi Chen; Haidong Wang; Zhenzhou Yang; Chan Gao; Shangli Cai; Yong He
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes
Valeria Santini; David Valcárcel; Uwe Platzbecker; Rami S. Komrokji; Ann L. Cleverly; Michael M. Lahn; Jan Janssen; Yumin Zhao; Alan Chiang; Aristoteles Giagounidis; Susan C. Guba; Ivelina Gueorguieva; Allicia C. Girvan; Mariana da Silva Ferreira; Tushar D. Bhagat; Kith Pradhan; Ulrich Steidl; Ashwin Sridharan; Britta Will; Amit Verma
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Brad S. Kahl; Mehdi Hamadani; John Radford; Carmelo Carlo-Stella; Paolo Caimi; Erin Reid; Jay M. Feingold; Kirit M. Ardeshna; Melhem Solh; Leonard T. Heffner; David Ungar; Shui He; Joseph Boni; Karin Havenith; Owen A. O'Connor
Clinical Trials: Immunotherapy
Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
Zi-Xun Yan; Li Li; Wen Wang; Bin-Shen OuYang; Shu Cheng; Li Wang; Wen Wu; Peng-Peng Xu; Muharrem Muftuoglu; Ming Hao; Su Yang; Mu-Chen Zhang; Zhong Zheng; James Li; Wei-Li Zhao
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma
Joseph M. Tuscano; Emanual Maverakis; Susan Groshen; Denice Tsao-Wei; Guillaume Luxardi; Alexander A. Merleev; Anne Beaven; John F. DiPersio; Leslie Popplewell; Robert Chen; Mark Kirschbaum; Mark A. Schroeder; Edward M. Newman
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer
Christian Lohrmann; Eileen M. O'Reilly; Joseph A. O'Donoghue; Neeta Pandit-Taskar; Jorge A. Carrasquillo; Serge K. Lyashchenko; Shutian Ruan; Rebecca Teng; Wolfgang Scholz; Paul W. Maffuid; Jason S. Lewis; Wolfgang A. Weber
Precision Medicine and Imaging
Author Choice
Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Andrew Georgiadis; Jennifer N. Durham; Laurel A. Keefer; Bjarne R. Bartlett; Magdalena Zielonka; Derek Murphy; James R. White; Steve Lu; Ellen L. Verner; Finey Ruan; David Riley; Robert A. Anders; Erika Gedvilaite; Sam Angiuoli; Siân Jones; Victor E. Velculescu; Dung T. Le; Luis A. Diaz, Jr; Mark Sausen
Author Choice
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Jason Willis; Martina I. Lefterova; Alexander Artyomenko; Pashtoon Murtaza Kasi; Yoshiaki Nakamura; Kabir Mody; Daniel V.T. Catenacci; Marwan Fakih; Catalin Barbacioru; Jing Zhao; Marcin Sikora; Stephen R. Fairclough; Hyuk Lee; Kyoung-Mee Kim; Seung Tae Kim; Jinchul Kim; Danielle Gavino; Manuel Benavides; Nir Peled; Timmy Nguyen; Mike Cusnir; Ramez N. Eskander; Georges Azzi; Takayuki Yoshino; Kimberly C. Banks; Victoria M. Raymond; Richard B. Lanman; Darya I. Chudova; AmirAli Talasaz; Scott Kopetz; Jeeyun Lee; Justin I. Odegaard
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj; Irene Scarfò; Maria L. Cabral; Stefanie R. Bailey; Selena J. Lorrey; Amanda A. Bouffard; Ana P. Castano; Rebecca C. Larson; Lauren S. Riley; Andrea Schmidts; Bryan D. Choi; Rikke S. Andersen; Oriane Cédile; Charlotte G. Nyvold; Jacob H. Christensen; Morten F. Gjerstorff; Henrik J. Ditzel; David M. Weinstock; Torben Barington; Matthew J. Frigault; Marcela V. Maus
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
Loren K. Mell; Hanjie Shen; Phuc Felix Nguyen-Tân; David I. Rosenthal; Kaveh Zakeri; Lucas K. Vitzthum; Steven J. Frank; Peter B. Schiff; Andy M. Trotti, III; James A. Bonner; Christopher U. Jones; Sue S. Yom; Wade L. Thorstad; Stuart J. Wong; George Shenouda; John A. Ridge; Qiang E. Zhang; Quynh-Thu Le
Translational Cancer Mechanisms and Therapy
Response to Anti-EGFR Therapy in Patients with BRAF non-V600–Mutant Metastatic Colorectal Cancer
Rona Yaeger; Daisuke Kotani; Sebastián Mondaca; Aparna R. Parikh; Hideaki Bando; Emily E. Van Seventer; Hiroya Taniguchi; HuiYong Zhao; Claire N. Thant; Elisa de Stanchina; Neal Rosen; Ryan B. Corcoran; Takayuki Yoshino; Zhan Yao; Hiromichi Ebi
Author Choice
Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma
Steven B. Maron; Leah M. Chase; Samantha Lomnicki; Sara Kochanny; Kelly L. Moore; Smita S. Joshi; Stacie Landron; Julie Johnson; Lesli A. Kiedrowski; Rebecca J. Nagy; Richard B. Lanman; Seung Tae Kim; Jeeyun Lee; Daniel V.T. Catenacci
Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach
Jason C. Chang; Deepu Alex; Matthew Bott; Kay See Tan; Venkatraman Seshan; Andrew Golden; Jennifer L. Sauter; Darren J. Buonocore; Chad M. Vanderbilt; Sounak Gupta; Patrice Desmeules; Francis M. Bodd; Gregory J. Riely; Valerie W. Rusch; David R. Jones; Maria E. Arcila; William D. Travis; Marc Ladanyi; Natasha Rekhtman
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma
Xin Xu; Wei Huang; Andras Heczey; Daofeng Liu; Linjie Guo; Michael Wood; Jingling Jin; Amy N. Courtney; Bin Liu; Erica J. Di Pierro; John Hicks; Gabriel A. Barragan; Ho Ngai; Yuhui Chen; Barbara Savoldo; Gianpietro Dotti; Leonid S. Metelitsa
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Louise Walsh; Kathryn E. Haley; Bruce Moran; Brian Mooney; Finbarr Tarrant; Stephen F. Madden; Alessandra Di Grande; Yue Fan; Sudipto Das; Oscar M. Rueda; Catríona M. Dowling; Damir Varešlija; Suet-Feung Chin; Sabine Linn; Leonie S. Young; Karin Jirström; John P. Crown; Rene Bernards; Carlos Caldas; William M. Gallagher; Darran P. O'Connor; Tríona Ní Chonghaile
A Novel HER3-Targeting Antibody–Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization
Yuuri Hashimoto; Kumiko Koyama; Yasuki Kamai; Kenji Hirotani; Yusuke Ogitani; Akiko Zembutsu; Manabu Abe; Yuki Kaneda; Naoyuki Maeda; Yoshinobu Shiose; Takuma Iguchi; Tomomichi Ishizaka; Tsuyoshi Karibe; Ichiro Hayakawa; Koji Morita; Takashi Nakada; Taisei Nomura; Kenichi Wakita; Takashi Kagari; Yuki Abe; Masato Murakami; Suguru Ueno; Toshinori Agatsuma
Author Choice
Bioactivation of Napabucasin Triggers Reactive Oxygen Species–Mediated Cancer Cell Death
Fieke E.M. Froeling; Manojit Mosur Swamynathan; Astrid Deschênes; Iok In Christine Chio; Erin Brosnan; Melissa A. Yao; Priya Alagesan; Matthew Lucito; Juying Li; An-Yun Chang; Lloyd C. Trotman; Pascal Belleau; Youngkyu Park; Harry A. Rogoff; James D. Watson; David A. Tuveson
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
David A. Schaer; Sandaruwan Geeganage; Nelusha Amaladas; Zhao Hai Lu; Erik R. Rasmussen; Andreas Sonyi; Darin Chin; Andrew Capen; Yanxia Li; Catalina M. Meyer; Bonita D. Jones; Xiaodong Huang; Shuang Luo; Carmine Carpenito; Kenneth D. Roth; Alexander Nikolayev; Bo Tan; Manisha Brahmachary; Krishna Chodavarapu; Frank C. Dorsey; Jason R. Manro; Thompson N. Doman; Gregory P. Donoho; David Surguladze; Gerald E. Hall; Michael Kalos; Ruslan D. Novosiadly
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
Victoria E. Wang; Jenny Y. Xue; Dennie T. Frederick; Yi Cao; Eva Lin; Catherine Wilson; Anatoly Urisman; David P. Carbone; Keith T. Flaherty; Rene Bernards; Piro Lito; Jeff Settleman; Frank McCormick
NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells
Cynthia Chauvin; Noémie Joalland; Jeanne Perroteau; Ulrich Jarry; Laura Lafrance; Catherine Willem; Christelle Retière; Lisa Oliver; Catherine Gratas; Laetitia Gautreau-Rolland; Xavier Saulquin; François M. Vallette; Henri Vié; Emmanuel Scotet; Claire Pecqueur
Advertisement